Ingredient dossier Nº 009 / The verified record
Azelaic Acid
AZELAIC ACID
Effective concentration, the pH it needs, how the derivatives compare, stability in the bottle, and the open questions — every scientific claim on this page links to its source.
- antimicrobial
- anti-inflammatory
- skin-conditioning agent
- tyrosinase inhibitor
- keratolytic
- comedolytic
Editorial verdict / Social intelligence
The dermatology world's best-kept multitasker — quietly excellent for rosacea, PIH, and pregnancy-safe acne care, but OTC 10% is the diet version of the clinical-strength formula that actually earned the data. 1
- Beauty benefit
- Azelaic acid quietly handles three of the hardest skin problems at once — acne, rosacea, and hyperpigmentation/PIH — through four simultaneous mechanisms, all in a single ingredient that is pregnancy-safe and won't make you sun-sensitive. The catch: the OTC 10% most people buy is weaker than the clinical-grade 15–20% that earned all the trial data, and every form of it works slowly.
- Does it work
- Yes — with an honest asterisk. At prescription strength (15% for rosacea, 20% for acne/melasma) it is FDA-approved with multiple phase 3 trial wins behind it. At 15%, it outperformed metronidazole 0.75% for rosacea and matched clindamycin for acne in head-to-head trials. For PIH and melasma its tyrosinase inhibition is real and selective: it preferentially targets overactive melanocytes, so it fades dark spots without bleaching surrounding normal skin — an edge over hydroquinone. The honest OTC-10% reality: all clinical evidence comes from Rx formulations; no peer-reviewed RCT has independently tested 10%. OTC products work, but more slowly and less powerfully. The pregnancy-safe rec is one of a kind: when retinoids, benzoyl peroxide oral antibiotics are off the table, azelaic acid is the derm-consensus go-to and more effective than topical antibiotics in a 2025 retrospective. See the science below →
Consensus strength
StrongStrong derm and editorial consensus across AAD, Westlake Dermatology, Dr Sam Bunting, Skin + Me, Johns Creek Dermatology, WebMD, Healthline, and Eminence Organics that azelaic acid is a legitimate multitasker with real clinical data. Prescription 15–20% has FDA approval for two indications and multiple phase 3 trials. Pregnancy-safe status is endorsed by the AAD explicitly. The OTC-10% limitation is acknowledged honestly across Westlake Dermatology, Chemist Confessions, and Simple Skincare Science. Community consensus (skincareaddiction proxy sources) identifies stinging, slow timeline, and gritty texture as the primary complaints alongside enthusiasm for its tolerance advantage over retinoids and benzoyl peroxide. No significant dissenting view on mechanism or safety.
01 / What it does
What it does
Azelaic acid is a naturally occurring straight-chain C9 dicarboxylic acid (found in wheat, rye, and barley) with four distinct pharmacological mechanisms: (1) antibacterial activity against Cutibacterium acnes via inhibition of bacterial mitochondrial oxidoreductase enzymes and thioredoxin reductase; (2) anti-inflammatory activity through inhibition of neutrophil-generated reactive oxygen species (ROS) and downregulation of pro-inflammatory cytokines; (3) reversible competitive inhibition of tyrosinase, with selective cytotoxicity against hyperactive and malignant melanocytes while sparing normal melanocytes; (4) normalization of follicular keratinization via antiproliferative effects on keratinocytes. It is one of the few topical actives with FDA-approved indications for both rosacea (Finacea 15%) and acne (Azelex 20%), and one of the very few actives considered compatible with pregnancy.
- Study Azelaic acid inhibits bacterial mitochondrial oxidoreductase enzymes essential for microbial respiration and protein synthesis in C. acnes, with intracellular concentrations in bacteria reported to exceed ambient concentrations by over 90-fold. 1
- Study Azelaic acid markedly decreases superoxide (O2-) and hydroxyl radical (OH.) generated by neutrophils, reducing oxidative tissue injury at inflammatory sites and contributing to melanin reduction. 2
- Study Azelaic acid competitively inhibits tyrosinase activity and selectively inhibits hyperactive melanocyte proliferation and DNA synthesis without significantly affecting normal melanocytes, reducing the risk of hypopigmentation in adjacent healthy skin. 3
- Study Azelaic acid normalizes disturbed terminal differentiation of keratinocytes in the follicular infundibulum; intra- and interfollicular hyperkeratosis is significantly reduced or normalized after 8-12 weeks of twice-daily treatment. 12
02 / Effective concentration
What percentage actually works
Effective range
10-20%
OTC products (e.g., 10% suspension) show clinical activity; FDA-approved Rx formulations are 15% (rosacea) and 20% (acne/melasma). No head-to-head data establishes minimum effective OTC concentration.
FDA-approved prescription formulations are Finacea Gel/Foam 15% (rosacea) and Azelex Cream 20% (acne). OTC products typically use ~10%, at the upper boundary of what is legally permitted outside Rx in many markets. The 10% OTC concentration includes penetration enhancers (e.g., dimethyl isosorbide in The Ordinary's suspension) to compensate for lower load; independent RCT data on 10% formulations specifically is limited. Azelaic acid is sparingly soluble in water (~2.4 g/L at 20°C), making high-concentration aqueous formulations technically challenging — Rx products use hydrogel, cream, or foam vehicles that suspend or partially dissolve the acid.
- Source Finacea (azelaic acid) gel 15% twice daily for 12 weeks was significantly superior to vehicle in two pivotal phase 3 trials for papulopustular rosacea (IGA success rate 43.4% vs 32.5%, p<0.001 in one trial). NDA:021470 ↗
- Study Finacea Foam 15% achieved a significantly greater IGA success rate versus vehicle at 12 weeks in a phase 3 randomized, double-blind, vehicle-controlled trial (PMID:26244354). 10
- Study Azelaic acid 15% gel twice daily achieved a 70% median reduction in inflammatory lesions (papules/pustules) compared to benzoyl peroxide 5% gel in 351 patients over 4 months; results were equivalent to 1% clindamycin in 229 patients. 9
One honest caveat No independent peer-reviewed RCT has specifically tested a 10% OTC azelaic acid formulation (the most common consumer-market concentration) for any indication. All clinical evidence comes from 15% or 20% Rx formulations.
03 / pH requirement
The pH it needs
Target pH
No strict pH requirement for efficacy; formulates across a broad range
Unlike L-ascorbic acid, azelaic acid does not require an acidic pH to penetrate the stratum corneum; it is a neutral molecule (not ionizable at skin-relevant pH). Marketed formulations range from approximately pH 3.5 to 5.5. This pH flexibility is a practical formulation advantage. The challenge is water solubility (sparingly soluble ~2.4 g/L), not pH. Gels and foam formulations use polymer matrices and surfactants to suspend micronized azelaic acid particles.
- Review Azelaic acid is a non-ionizable dicarboxylic acid at physiological pH; formulated products span pH ~3.5-5.5 without the strict sub-3.5 requirement needed for L-ascorbic acid. 14
04 / Derivative ladder
How the derivatives compare
Every derivative trades a measure of proven activity for stability or gentleness. Skin conversion is the question that matters — a more stable molecule only helps if your skin can turn it back into the active form.
-
Potassium Azeloyl Diglycinate
- Study A cream containing 5% potassium azeloyl diglycinate and 1% hydroxypropyl chitosan applied twice daily for 4 weeks significantly reduced erythema versus placebo in a pilot RCT of 42 rosacea patients. 15
- Study Potassium azeloyl diglycinate combined with tranexamic acid and niacinamide in a topical emulsion reduced melasma severity in Thai adults in a randomized double-blind controlled study over 8 weeks. 16
05 / Stability & storage
Stability in the bottle
Azelaic acid is a chemically stable dicarboxylic acid with excellent shelf stability compared to oxidation-prone actives like L-ascorbic acid. It does not require special packaging (opaque/airless) or antioxidant co-stabilizers. The primary formulation challenge is physical suspension stability at high concentrations (the ~10% OTC suspension format from The Ordinary separates over time and must be shaken). Thermal stability is high. No significant photodegradation has been documented.
- Review Azelaic acid is chemically stable under standard storage conditions and does not undergo the rapid oxidative degradation seen with ascorbic acid; the primary formulation challenge is solubilizing sufficient concentration in aqueous vehicles. 14
In practice Buy it in an opaque, airless, or amber container, store it cool and out of the light, and treat a colour shift toward orange or brown as the signal to replace it — the molecule is telling you it has already oxidised.
06 / How to use it
How to actually use Azelaic Acid
- When
- AM or PM — After cleansing, before moisturizer.
- Pairs well with
- niacinamide, most actives.
- Apply apart from
- Nothing major — it layers comfortably with most actives.
- What to look for
- 10% over-the-counter (15–20% by prescription).
- Heads-up
- Plays well with almost everything (even retinoids). Can tingle at first; generally gentle and a common pregnancy-safe pick — confirm with your doctor.
Practical guidance for routine placement — not a substitute for a dermatologist’s advice for your skin.
07 / The database
Every Azelaic Acid product, cheapest active-gram first
Ranked by $ per gram of active — what the working ingredient actually costs you, not the sticker price. Rows we have reviewed in full link through; the rest are data points from the same crawl.
Buy The Ordinary on Amazon $12.20 Top-ranked pick · affiliate link
| # | Product | % | Price | $ / g of active |
|---|---|---|---|---|
| 1 | Good Molecules 10% Azelaic Acid Treatment Ulta | 10% | $12.00 | $4.06 |
| 2 | The Ordinary Azelaic Acid Suspension 10% Cream for Redness and Blemish-Prone Skin Reviewed in full | 10% | $12.20 | $4.13 |
| 3 | Paula's Choice 10% Azelaic Acid Booster Reviewed in full | 10% | $27.30 | $9.23 |
Showing the 3 lowest-cost of 3 measured .
Contains it, but doesn't disclose a percentage: BubbleKnock Out 1.8% Salicylic Acid Acne Spot Treatment ; The OrdinaryAzelaic Acid Suspension 10% Cream for Redness and Blemish-Prone Skin ; Urban Skin RxEven Tone Cleansing Bar 3-in-1 Treatment - 2.0 oz ; BubbleMoon Walk Gentle Exfoliating Serum ; BubbleDream Fade Discoloration Rescue Serum ; Urban Skin RxWitch Hazel Brightening & pH Balancing Toner — and 14 more.
08 / Safety
Is it safe?
Reviewed by the Cosmetic Ingredient Review — safe as used
Safe as used — Final Report of the Cosmetic Ingredient Review Expert Panel on the Safety Assessment of Dicarboxylic Acids, Salts, and Esters (Fiume et al., 2012, Int J Toxicol 31(4_suppl):5S-76S; DOI:10.1177/1091581812447203). Panel explicitly reviewed azelaic acid (C9) and its salts (dipotassium azelate, disodium azelate) and concluded the ingredients 'are safe in the present practices of use and concentration.'
Most common adverse effects in clinical trials are transient and local: stinging, burning, tingling, itching, and erythema at the application site, typically resolving within 2-4 weeks of continued use. These are more pronounced at 20% than 15%. Rare systemic absorption (approximately 4% of applied dose), so systemic effects are not expected with topical use. A theoretical risk of hypopigmentation in patients with very dark skin tones has been raised because of tyrosinase inhibition; however, the selective action on hyperactive melanocytes makes this less likely than with hydroquinone. The 2025 pregnancy retrospective (PMID:40873252) found no difference in adverse effects between azelaic acid, erythromycin, and clindamycin groups.
- CIR Azelaic acid and its cosmetically used dicarboxylic acid derivatives are safe in present practices of use and concentration, per CIR Expert Panel review covering animal, clinical, and toxicological data. doi ↗
- Source Approximately 4% of a topical azelaic acid dose is systemically absorbed after a single application; plasma levels remain within the normal endogenous range, as azelaic acid is produced naturally by skin flora and found in plasma of all individuals. NDA:020428 ↗
09 / The limits of the evidence
What we don't know yet
Most of what you read about this ingredient is stated with more certainty than the evidence earns. Here is exactly where the record thins out — so you can weigh the claims above for yourself.
- No independent peer-reviewed RCT has specifically tested a 10% OTC azelaic acid formulation (the most common consumer-market concentration) for any indication. All clinical evidence comes from 15% or 20% Rx formulations.
- The selective cytotoxicity on hyperactive vs normal melanocytes (PMID:2114832) is foundational to the safety profile, but the molecular mechanism of this selectivity is not fully characterized; increased membrane permeability in abnormal melanocytes is hypothesized but not confirmed.
- Most anti-inflammatory ROS data (PMID:1867478) comes from ex vivo neutrophil studies; in vivo quantification of ROS inhibition in rosacea skin after topical application has not been published.
- The 2025 pregnancy retrospective (PMID:40873252) involved only 26 patients in the azelaic acid arm; a large prospective controlled trial in pregnancy is still lacking, meaning the safety classification relies on low systemic absorption and preclinical data rather than powered human trials.
- Head-to-head comparison of azelaic acid 10% OTC versus prescription 15% in the same patients for PIH, acne, or rosacea has not been published in peer-reviewed literature.
- Long-term data (beyond 24 weeks) on sustained azelaic acid use for melasma maintenance are limited; relapse rates after discontinuation versus hydroquinone have not been systematically compared.
- Potassium azeloyl diglycinate (PAD) lacks head-to-head data against free azelaic acid; all PAD trials use multi-ingredient formulations, making it impossible to isolate PAD's contribution.
10 / What people say
What formulators and users say
What works
- Common Triple-threat multitasker: clinically effective for acne, rosacea, AND hyperpigmentation/PIH simultaneously — rare in a single topical ingredient 289
the secret underdog of skin success Dermatologist
- Common FDA-approved for rosacea (Finacea 15%) and acne (Azelex 20%) — one of very few topical OTC-adjacent actives with Rx approval for two separate indications 37
FDA-approved for the topical treatment of inflammatory papules and pustules of mild to moderate rosacea Dermatologist
- Common Selectively fades dark spots without bleaching surrounding normal skin — preferentially targets overactive melanocytes, making it safer than hydroquinone for darker skin tones and PIH 276
the best one for pigmentation — only second to hydroquinone in terms of potency Dermatologist
- Common Pregnancy Category B — one of only a handful of topical actives explicitly cleared for use during pregnancy by dermatologists and the AAD, making it uniquely valuable when retinoids, benzoyl peroxide, and most oral antibiotics are off-limits 154
This is thought to be safe to use during pregnancy. In animal studies, researchers haven't seen birth defects. Dermatologist
- Common Does not cause photosensitivity — unlike AHAs, benzoyl peroxide, and retinoids, azelaic acid can be used morning or evening without increasing sun sensitivity 119
Azelaic acid does not absorb UV and visible light, meaning that it is highly unlikely to cause sun sensitivity. Editorial
- Some Fungal-acne-safe with active antifungal properties — works against Malassezia folliculitis unlike most acne treatments, and gel/foam formats layer safely without feeding yeast 914
it's an effective treatment for fungal acne, or the skin conditions associated with malassezia Editorial
What to know
- Common Works slowly — expect 6–12 weeks before seeing meaningful results for acne or redness, and 3–6 months for full pigmentation clearance; not a quick-fix ingredient 7128
It may be a month before your skin improves. You may not see a positive change for 3 months [for rosacea]. Editorial
- Common Initial stinging, burning, and tingling on application — up to 29% of users experience this in the first 1–2 weeks, and it can be significant enough that some users stop before giving it a fair trial 129
Mild stinging and dryness, especially without moisturiser — this is normal and will usually subside within a couple of weeks Editorial
- Common OTC 10% products (The Ordinary, Paula's Choice, Naturium) are weaker than the prescription concentrations that earned all the clinical evidence — all head-to-head trial data comes from 15–20% Rx formulations 310
Prescription-strength (15–20%) is recommended for more persistent or medically diagnosed concerns; OTC as appropriate for easing in Dermatologist
- Some Texture and formulation issues with popular OTC products — The Ordinary's suspension is silicone-heavy, pills under makeup, and must be shaken; emulsion formats (Paula's Choice, Naturium, Inkey List) perform better but cost more 910
The Ordinary's product was 'SO siliconey' and caused pilling Editorial
- Some Melasma results are modest vs. hydroquinone — a 2023 meta-analysis of 6 RCTs found azelaic acid produced significantly lower mean MASI improvement than hydroquinone, so for stubborn melasma it's the safer-but-less-powerful option 162
Azelaic acid produced a lower mean MASI score change than hydroquinone (MD=-1.23, 95% CI -2.05 to -0.40, p=0.004) Study
What you'd only know from the reviews
-
Pregnancy-safe is not the same as 'works just as well in a milder form.' The 2025 retrospective (197 pregnant patients) found 20% azelaic acid was actually MORE effective than topical erythromycin or clindamycin for pregnancy acne — so choosing it during pregnancy is not a compromise, it's potentially the strongest option available. This is the one context where azelaic acid is the best tool on the table, not a workaround. 151
-
The clinical evidence base for azelaic acid is entirely built on 15–20% prescription formulations — no peer-reviewed RCT has specifically tested a 10% OTC formulation for acne, rosacea, or melasma. When brands market 10% OTC as 'clinically studied,' they are borrowing the credibility of Rx trials. This doesn't mean 10% doesn't work, but it does mean results are empirically slower and the dosing is unvalidated against any outcome measure. 1017
-
Azelaic acid's anti-rosacea mechanism is distinct from its acne mechanism — for rosacea it works by modulating Toll-like receptor 2 (TLR2) signaling and suppressing cathelicidin overexpression (the pathway behind flushing and inflammation), not just by killing bacteria. This is why it works for rosacea patients who don't have acne at all, and why it's approved as a first-line Rx treatment rather than an alternative to antibiotics. 213
-
The initial stinging most users report is not a red flag — it's transient and typically resolves within 2–4 weeks. Buffering (applying a light moisturizer before the azelaic acid) significantly reduces the sensation while not meaningfully reducing efficacy. Most users who quit in the first two weeks due to stinging would have seen it disappear by week 3–4. 129
-
Azelaic acid is one of the only active ingredients that can be used morning or evening with equal safety — it does not increase photosensitivity and no cases of photo-irritation have been documented in clinical trials. The preference for evening use is purely practical (texture doesn't always layer under SPF/makeup well), not a safety requirement. This makes it more flexible to build a routine around than AHAs, retinoids, or even benzoyl peroxide. 119
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
11 / Questions
Frequently asked
- What does azelaic acid do for skin?
- Azelaic acid works through four simultaneous mechanisms: it kills acne-causing bacteria (Cutibacterium acnes) by disrupting bacterial respiratory enzymes; it reduces inflammation by scavenging reactive oxygen species and inhibiting neutrophil oxidative activity; it fades dark spots by blocking tyrosinase (the enzyme that makes melanin), with a selective preference for overactive melanocytes; and it prevents comedone formation by normalizing keratinocyte turnover in the hair follicle. This multi-mechanism profile makes it one of the few topical actives effective for acne, rosacea, and hyperpigmentation simultaneously. The FDA has approved it at 15% for rosacea (Finacea) and at 20% for acne (Azelex). 12312
- Is azelaic acid safe during pregnancy?
- Azelaic acid is one of the very few topical actives that dermatologists and obstetricians broadly consider acceptable during pregnancy. It was historically classified as FDA Pregnancy Category B (animal studies showed no fetal harm; no adequate human trials exist, which is the case for virtually all topical actives). Approximately 4% of the topical dose is absorbed systemically — and crucially, azelaic acid is a naturally occurring substance already present in human plasma from dietary sources and skin microbiome metabolism, so even the small absorbed amount falls within the normal physiological range. A 2025 retrospective study of 197 pregnant patients found 20% azelaic acid was more effective than topical erythromycin or clindamycin for acne, with no difference in side effects across groups (PMID:40873252). This makes it particularly valuable when retinoids (teratogenic, contraindicated), salicylic acid (high doses contraindicated), and oral antibiotics are being avoided. Always confirm with a treating physician. 13ref
- Is azelaic acid effective for rosacea?
- Yes — it is FDA-approved for rosacea. Finacea 15% gel was first approved in 2002, and Finacea 15% foam was approved in 2015. A phase 3 randomized, double-blind trial (n>600) showed AzA foam 15% achieved a significantly greater IGA success rate versus vehicle at 12 weeks (PMID:26244354). A head-to-head randomized trial of 251 patients with papulopustular rosacea found 15% azelaic acid gel was superior to 0.75% metronidazole gel in reduction of inflammatory lesions at 15 weeks (PMID:15492198). The anti-inflammatory mechanism (ROS inhibition, cathelicidin downregulation) directly addresses key pathways implicated in rosacea pathophysiology. 10112
- Does azelaic acid help dark spots, PIH, and melasma?
- Yes, and with important nuance. Azelaic acid inhibits tyrosinase competitively and reversibly, and — uniquely — it preferentially targets hyperactive or abnormal melanocytes while leaving normal melanocytes intact. This means it fades excess pigment without bleaching normal skin tone, a meaningful safety advantage over hydroquinone which can permanently depigment. A 16-week baseline-controlled study of 15% gel found significant improvements in both post-inflammatory hyperpigmentation (PIH) and acne together (PMID:21637899). For melasma, a 2023 systematic review and meta-analysis of 6 RCTs (n=673) found azelaic acid produced a lower mean MASI score change than hydroquinone (PMID:37457606), while the classic 24-week double-blind RCT comparing 20% AzA cream to 4% hydroquinone in 329 women found comparable results (PMID:1816137). Side effect profiles favor azelaic acid over hydroquinone. 8753
- What percentage of azelaic acid is effective OTC?
- FDA-approved clinical data comes from 15% (rosacea) and 20% (acne/melasma) prescription formulations. OTC products typically use ~10%, which is the practical ceiling for non-prescription products in most markets. No peer-reviewed RCT has independently tested a 10%-only formulation head-to-head against Rx concentrations. The Ordinary's 10% suspension and similar OTC products use penetration enhancers (dimethyl isosorbide) to partially compensate for lower load. User-reported outcomes are generally positive for mild PIH and redness, but the published evidence base for 10% specifically is limited; for clinical-strength results especially on melasma and acne, prescription 15-20% formulations have the supporting data. 109
- Azelaic acid vs niacinamide vs vitamin C for brightening — which is better?
- These actives work through different mechanisms and are often complementary rather than competitive. Azelaic acid inhibits tyrosinase competitively and reversibly, and has the added property of selectively targeting hyperactive melanocytes (PMID:2114832) — making it particularly well-suited for PIH on medium-to-deeper skin tones where other actives risk over-bleaching. Niacinamide works by inhibiting melanosome transfer from melanocytes to keratinocytes (a downstream step) rather than tyrosinase production itself. L-ascorbic acid reduces melanin by inhibiting tyrosinase at its copper active site and also provides antioxidant photoprotection. For PIH specifically, azelaic acid is preferred in pregnancy (safe) and where hydroquinone is contraindicated. For overall brightening + antioxidant photoprotection, vitamin C 15%+ at pH < 3.5 has strong penetration data. Niacinamide is the most tolerable. No direct head-to-head three-way clinical trial exists comparing all three for hyperpigmentation endpoints. 387
12 / References
Sources
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19